Target intelligence / Profile preview

Pseudomonas aeruginosa Lipopolysaccharide (LPS)

Target
LPS
Molecular classification
Glycolipid, Cell surface antigen
01

Overview

Pseudomonas aeruginosa lipopolysaccharide (LPS) is a major component of the outer membrane of this Gram-negative bacterium. It plays a critical role in the organism’s structural integrity, virulence, and interactions with host immune systems. LPS is essential for bacterial survival and pathogenicity, contributing to resistance against host defenses and antibiotics. LPS consists of three main regions: Lipid A (endotoxin), core oligosaccharide, and O-antigen. As a virulence factor it protects P. aeruginosa from environmental threats including antimicrobial peptides and complement-mediated killing. Host pattern recognition receptors detect lipid A moieties through TLR4/MD2/CD14 complexes, triggering inflammatory responses that can lead to sepsis if uncontrolled. Variations in LPS structure during biofilm growth enhance bacterial persistence and resistance mechanisms within host tissues or medical devices.

Other names
P. aeruginosa LPSP. aeruginosa EndotoxinLipopolysaccharide
02

Mechanism of action

Polymyxins bind to lipid A, disrupting the bacterial membrane. TLR4 antagonists block LPS-induced immune activation.

03

Biological functions

Immune evasionBiofilm formationAntibiotic resistanceOuter membrane integrityTLR4 activation
04

Disease associations

InfectionSepsisCystic FibrosisNosocomial infectionsInflammation
05

Safety considerations

Sepsis induction via TLR4 activationStructural heterogeneity complicates vaccine developmentPotential for off-target effects when targeting TLR4
06

Interacting drugs

Polymyxins

1 more in the full profile.

07

Biomarkers

LPS levels in serum (sepsis)Anti-LPS antibodies

Beyond the preview

Go deeper on Pseudomonas aeruginosa Lipopolysaccharide (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa Lipopolysaccharide (LPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call